On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its digital and quantitative polymerase chain reaction (Digital PCR and qPCR) COVID-19 testing kits in North America, Europe, Southeast Asia and Latin America.

In addition, the Company announced that Gnomegen’s qPCR test received Emergency Use Authorization from the FDA diagnostic test for COVID-19 on May 8th, 2020. Further, the Company announced that it had completed validation testing for the Gnomegen qPCR reagents and was entering preparations to commercially launch the test in the United States through its partner CLIA lab.